BR112015011986A2 - síntese de compostos de absorção de uv - Google Patents

síntese de compostos de absorção de uv

Info

Publication number
BR112015011986A2
BR112015011986A2 BR112015011986A BR112015011986A BR112015011986A2 BR 112015011986 A2 BR112015011986 A2 BR 112015011986A2 BR 112015011986 A BR112015011986 A BR 112015011986A BR 112015011986 A BR112015011986 A BR 112015011986A BR 112015011986 A2 BR112015011986 A2 BR 112015011986A2
Authority
BR
Brazil
Prior art keywords
product
compound synthesis
absorption compound
synthesis
reducing
Prior art date
Application number
BR112015011986A
Other languages
English (en)
Inventor
Ryan John
York Mark
Original Assignee
Coral Sunscreen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012905185A external-priority patent/AU2012905185A0/en
Application filed by Coral Sunscreen Pty Ltd filed Critical Coral Sunscreen Pty Ltd
Publication of BR112015011986A2 publication Critical patent/BR112015011986A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)

Abstract

resumo patente de invenção: "síntese de compostos de absorção de uv". um método de síntese é proporcionado para obter uma faixa de compostos de absorção de uv. o método envolve amplamente (a) a redução de uma glutarimida, ou sua reação com um nucleófilo de carbono; (b) quando a etapa (a) é uma redução, a exposição do produto da etapa (a) a um ambiente ácido para formar uma amida cíclica; (c) redução do produto da etapa (a) ou etapa (b), para formar uma enamina correspondente; e submeter o produto de enamina da etapa (c) a uma acilação.
BR112015011986A 2012-11-27 2013-11-27 síntese de compostos de absorção de uv BR112015011986A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012905185A AU2012905185A0 (en) 2012-11-27 Synthesis of uv absorbing compounds
AU2013901952A AU2013901952A0 (en) 2013-05-29 Synthesis of uv absorbing compounds
PCT/AU2013/001372 WO2014082124A1 (en) 2012-11-27 2013-11-27 Synthesis of uv absorbing compounds

Publications (1)

Publication Number Publication Date
BR112015011986A2 true BR112015011986A2 (pt) 2017-07-11

Family

ID=50826956

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015011986A BR112015011986A2 (pt) 2012-11-27 2013-11-27 síntese de compostos de absorção de uv

Country Status (10)

Country Link
US (1) US20150299124A1 (pt)
EP (1) EP2925724A4 (pt)
JP (1) JP2016506374A (pt)
KR (1) KR20150090207A (pt)
CN (1) CN104903292A (pt)
AU (1) AU2013351912B2 (pt)
BR (1) BR112015011986A2 (pt)
CA (1) CA2892395A1 (pt)
SG (1) SG11201504138QA (pt)
WO (1) WO2014082124A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3022180B1 (en) * 2013-07-15 2022-02-23 Coral Sunscreen Pty Ltd Uv absorbing compounds, compositions comprising same and uses thereof
US10519111B2 (en) 2013-07-15 2019-12-31 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof
KR20180087134A (ko) 2015-11-27 2018-08-01 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 광안정성 화합물, 흡수성 화합물 및 이들의 용도
AU2016329043A1 (en) * 2015-12-23 2017-07-13 Commonwealth Scientific And Industrial Research Organisation Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221849A (en) * 1986-09-26 1990-09-26 Ici Australia Operations Sunscreen compositions containing tetrahydropyridines
AU3564889A (en) * 1988-06-03 1990-01-05 Upjohn Company, The Cyclic lactams for cholesterol and atherosclerosis control
US5637718A (en) * 1989-02-23 1997-06-10 Ici Australia Operations Proprietary Ltd. UV-absorbing compounds

Also Published As

Publication number Publication date
WO2014082124A1 (en) 2014-06-05
SG11201504138QA (en) 2015-06-29
US20150299124A1 (en) 2015-10-22
AU2013351912B2 (en) 2016-02-11
CN104903292A (zh) 2015-09-09
CA2892395A1 (en) 2014-06-05
AU2013351912A1 (en) 2015-06-04
KR20150090207A (ko) 2015-08-05
EP2925724A1 (en) 2015-10-07
JP2016506374A (ja) 2016-03-03
EP2925724A4 (en) 2016-06-15

Similar Documents

Publication Publication Date Title
CY1118187T1 (el) Χημικες ενωσεις
GEP20166438B (en) Imidazopyrrolidinone compounds
UY33735A (es) Compuestos antivirales
MX2008012404A (es) Derivados de amida y su aplicacion para el tratamiento de enfermedades relacionadas con proteina-g.
EA201071320A1 (ru) Активаторы глюкокиназы
MX368781B (es) Compuesto inhibidor de las actividades de las cinasas btk y/o jak3.
BRPI1012082A2 (pt) composição aquosa , método para preparar um composição de igg concentrada a partir de plasma , e, uso da composição.
BR112015000399A2 (pt) derivados de pirazolil pirimidina
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
UY28473A1 (es) Nuevos compuestos
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
BRPI0911907B8 (pt) processo para produzir uma composição contendo triptofano e composição proteica contendo triptofano
SV2011003903A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa iv para el tratamiento o prevencion de diabetes
BR112015004666A2 (pt) derivados de indol carboxamida e usos dos mesmos
CY1112725T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
CR20140494A (es) Inhibidores de dgat1 de eter ciclico de cabeza de puente
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
CY1115590T1 (el) Σουλφοξιμινυποκατεστημενα παραγωγα ανιλινοπυριμιδινης ως cdk-αναστολεις, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
CR20140553A (es) Compuestos de fenoxietil piperidina
MX2014004858A (es) Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas.
BR112015020904A2 (pt) microrganismos e métodos para produção de butadieno e compostos relacionados por assimilação de formiato
GEP201706621B (en) Benzamides
IN2014CN02273A (pt)

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)